compound semaglutide or tirzepatide FDA says 'no clinical need' for compounded weight loss drugs Concerns Surrounding Compounded GLP-1s Mount
Description
Retatrutide and tirzepatide are innovative medications showing promising potential for weight loss and improving metabolic health, particularly in managing obesity and type 2 diabetes
Clinics, including obesity and metabolic health centers, offer focused care with shorter wait times and more frequent patient follow-ups, which appeals to individuals seeking targeted weight loss treatments like GLP-1 therapies
Three scenarios illustrating ethical concerns when considering bariatric surgery in obese adolescents with Prader-Willi syndrome
Synthetic biology
Head to this page to learn more
